Literature DB >> 23784897

Circulating cortisol-associated signature of glucocorticoid-related gene expression in subcutaneous fat of obese subjects.

Maria G Pavlatou1, Kasey C Vickers, Sudhir Varma, Rana Malek, Maureen Sampson, Alan T Remaley, Philip W Gold, Monica C Skarulis, Tomoshige Kino.   

Abstract

OBJECTIVE: Serum cortisol concentrations fluctuate in a circadian fashion, and glucocorticoids exert strong effects on adipose tissue and induce obesity through the glucocorticoid receptor. DESIGN AND METHODS: To examine the impact of physiologic levels of circulating cortisol on subcutaneous adipose tissue, 25 overweight and obese subjects were employed, and their serum levels of morning (AM) and evening (PM) cortisol, AM/PM cortisol ratios, and 24-h urinary-free cortisol (UFC) were compared with their clinical parameters, serum cytokine levels, and mRNA expression of 93 receptor action-regulating and 93 glucocorticoid-responsive genes in abdominal subcutaneous fat. RESULTS AND
CONCLUSIONS: AM cortisol levels did not correlate with mRNA expression of the all genes examined, whereas PM cortisol levels, AM/PM cortisol ratios, and 24-h UFC were associated with distinct sets of these genes. Body mass index did not significantly correlate with the four cortisol parameters employed. These results suggest that physiologic levels of AM serum cortisol do not solely represent biological effects of circulating cortisol on the expression of glucocorticoid-related genes in subcutaneous adipose tissue, whereas PM levels, amplitude, and net amounts of the diurnally fluctuating serum cortisol have distinct effects. Through the genes identified in this study, glucocorticoids appear to influence intermediary metabolism, energy balance, inflammation, and local circadian rythmicity in subcutaneous fat. Our results may also explain in part the development of metabolic abnormality and obesity in subjects under stress or patients with melancholic/atypical depression who demonstrate elevated levels of PM serum cortisol.
Copyright © 2013 The Obesity Society.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23784897      PMCID: PMC4199221          DOI: 10.1002/oby.20073

Source DB:  PubMed          Journal:  Obesity (Silver Spring)        ISSN: 1930-7381            Impact factor:   5.002


  36 in total

Review 1.  Resistin, obesity, and insulin resistance--the emerging role of the adipocyte as an endocrine organ.

Authors:  A R Shuldiner; R Yang; D W Gong
Journal:  N Engl J Med       Date:  2001-11-01       Impact factor: 91.245

2.  Estimation of VO2max from the ratio between HRmax and HRrest--the Heart Rate Ratio Method.

Authors:  Niels Uth; Henrik Sørensen; Kristian Overgaard; Preben K Pedersen
Journal:  Eur J Appl Physiol       Date:  2003-11-18       Impact factor: 3.078

Review 3.  Regulation of MAP kinase signaling modules by scaffold proteins in mammals.

Authors:  Deborah K Morrison; Roger J Davis
Journal:  Annu Rev Cell Dev Biol       Date:  2003       Impact factor: 13.827

4.  Purification and characterization of branched chain alpha-keto acid dehydrogenase complex of bovine kidney.

Authors:  F H Pettit; S J Yeaman; L J Reed
Journal:  Proc Natl Acad Sci U S A       Date:  1978-10       Impact factor: 11.205

5.  A transgenic model of visceral obesity and the metabolic syndrome.

Authors:  H Masuzaki; J Paterson; H Shinyama; N M Morton; J J Mullins; J R Seckl; J S Flier
Journal:  Science       Date:  2001-12-07       Impact factor: 47.728

Review 6.  Major depression and the stress system: a life span perspective.

Authors:  S E Meyer; G P Chrousos; P W Gold
Journal:  Dev Psychopathol       Date:  2001

Review 7.  New lessons in the regulation of glucose metabolism taught by the glucose 6-phosphatase system.

Authors:  G van de Werve; A Lange; C Newgard; M C Méchin; Y Li; A Berteloot
Journal:  Eur J Biochem       Date:  2000-03

Review 8.  Organization of the stress system and its dysregulation in melancholic and atypical depression: high vs low CRH/NE states.

Authors:  P W Gold; G P Chrousos
Journal:  Mol Psychiatry       Date:  2002       Impact factor: 15.992

9.  p38 Mitogen-activated protein kinase-induced glucocorticoid receptor phosphorylation reduces its activity: role in steroid-insensitive asthma.

Authors:  Elvis Irusen; John G Matthews; Atsushi Takahashi; Peter J Barnes; Kian F Chung; Ian M Adcock
Journal:  J Allergy Clin Immunol       Date:  2002-04       Impact factor: 10.793

10.  Protein 14-3-3sigma interacts with and favors cytoplasmic subcellular localization of the glucocorticoid receptor, acting as a negative regulator of the glucocorticoid signaling pathway.

Authors:  Tomoshige Kino; Emanuel Souvatzoglou; Massimo U De Martino; Maria Tsopanomihalu; Yihong Wan; George P Chrousos
Journal:  J Biol Chem       Date:  2003-05-01       Impact factor: 5.157

View more
  7 in total

1.  Glucocorticoid receptor ChIP-sequencing of subcutaneous fat reveals modulation of inflammatory pathways.

Authors:  Puneet Singh; Clifton O Brock; Paul A Volden; Kyle Hernandez; Maxwell Skor; Masha Kocherginsky; Julie E Park; Matthew J Brady; Suzanne D Conzen
Journal:  Obesity (Silver Spring)       Date:  2015-09-26       Impact factor: 5.002

2.  Neuroendocrine Stress Axis-Dependence of Duloxetine Analgesia (Anti-Hyperalgesia) in Chemotherapy-Induced Peripheral Neuropathy.

Authors:  Larissa Staurengo-Ferrari; Ivan J M Bonet; Dioneia Araldi; Paul G Green; Jon D Levine
Journal:  J Neurosci       Date:  2021-12-08       Impact factor: 6.709

3.  Altered expression of circadian clock genes in polyglandular autoimmune syndrome type III.

Authors:  Anna Angelousi; Narjes Nasiri-Ansari; Eliana Spilioti; Emilia Mantzou; Vasiliki Kalotyxou; George Chrousos; Gregory Kaltsas; Eva Kassi
Journal:  Endocrine       Date:  2017-09-07       Impact factor: 3.633

Review 4.  Recent advances in the molecular mechanisms determining tissue sensitivity to glucocorticoids: novel mutations, circadian rhythm and ligand-induced repression of the human glucocorticoid receptor.

Authors:  Nicolas C Nicolaides; Evangelia Charmandari; George P Chrousos; Tomoshige Kino
Journal:  BMC Endocr Disord       Date:  2014-08-25       Impact factor: 2.763

5.  ABCC1 modulates negative feedback control of the hypothalamic-pituitary-adrenal axis in vivo in humans.

Authors:  Catriona J Kyle; Mark Nixon; Natalie Z M Homer; Ruth A Morgan; Ruth Andrew; Roland H Stimson; Brian R Walker
Journal:  Metabolism       Date:  2022-01-04       Impact factor: 8.694

Review 6.  Depression in polycystic ovary syndrome: Focusing on pathogenesis and treatment.

Authors:  Liwei Xing; Jinlong Xu; Yuanyuan Wei; Yang Chen; Haina Zhuang; Wei Tang; Shun Yu; Junbao Zhang; Guochen Yin; Ruirui Wang; Rong Zhao; Dongdong Qin
Journal:  Front Psychiatry       Date:  2022-08-31       Impact factor: 5.435

7.  11β-Hydroxysteroid dehydrogenase type 1 (11β-HSD1) inhibitors still improve metabolic phenotype in male 11β-HSD1 knockout mice suggesting off-target mechanisms.

Authors:  Erika Harno; Elizabeth C Cottrell; Alice Yu; Joanne DeSchoolmeester; Pablo Morentin Gutierrez; Mark Denn; John G Swales; Fred W Goldberg; Mohammad Bohlooly-Y; Harriet Andersén; Martin J Wild; Andrew V Turnbull; Brendan Leighton; Anne White
Journal:  Endocrinology       Date:  2013-10-29       Impact factor: 4.736

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.